Inhaled corticosteroids should be the first line of treatment for children with asthma

Paediatric Respiratory Reviews

Volumn 12, Issue 4, 2011, Pages 245-249

  Brand, Paul L P ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Allergic rhinitis; Asthma; Budesonide; Exercise induced asthma; Fluticasone; Inhaled corticosteroids; Montelukast

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; MONTELUKAST; PLACEBO;

ADRENAL SUPPRESSION; ALLERGIC RHINITIS; ASTHMA; BONE DENSITY; BRONCHOSPASM; CATARACT; CHILD; CHILDHOOD ASTHMA; CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EXERCISE INDUCED ASTHMA; EXERCISE INDUCED BRONCHOCONSTRICTION; FRACTURE; GROWTH INHIBITION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAINTENANCE THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SIDE EFFECT; SYMPTOM; SYSTEMATIC REVIEW (TOPIC); UNSPECIFIED SIDE EFFECT; VIRUS INDUCED WHEEZE; VIRUS INFECTION; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; CHILD; HUMANS;

EID: 80955144136     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.05.009     Document Type: Review

References (47)

1. van Essen-Zandvliet E.E.M., Hughes M.D., Waalkens H.J., Duiverman E.J., Pocock S.J., Kerrebijn K.F., et al. Effects of 22 months of treatment with inhaled corticosteroids and/or β2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992, 146:547-554.
2. Waalkens H.J., van Essen-Zandvliet E.E.M., Hughes M.D., Gerritsen J., Duiverman E.J., Knol K., et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993, 148:1252-1257.
3. Merkus P.J.F.M., van Essen-Zandvliet E.E.M., Duiverman E.J., van Houwelingen J.C., Kerrebijn K.F., Quanjer P.H. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993, 91:1121-1126.
4. Bisgaard H., Munck S.L., Nielsen J.P., Petersen W., Ohlsson S.V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990, 336:649-651.
5. Pedersen S.E., Hurd S.S., Lemanske R.F., Becker A., Zar H.J., Sly P.D., et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011, 46:1-17.
6. Anderson M., Thomas D.A. Drug therapy for chronic asthma in children. Arch Dis Child Educ Pract Ed 2010, 95:145-150.
7. Bacharier L.B., Boner A., Carlsen K.H., Eigenmann P.A., Frischer T., Gotz M., et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008, 63:5-34.
8. (last assessed on Jan 26, 2011). http://www.ginasthma.com/.
9. del Giudice M.M., Pezzulo A., Capristo C., Alterio E., Caggiano S., de Benedictis D., et al. Leukotriene modifiers in the treatment of asthma in children. Ther Adv Respir Dis 2009, 3:245-251.
10. Scadding G.W., Scadding G.K. Recent advances in antileukotriene therapy. Curr Opin Allergy Clin Immunol 2010, 10:370-376.
11. Adams NP, Bestall JC, Jones P. Budesonide versus placebo for chronic asthma in children and adults. Cochrane Database of Systematic Reviews 1999, Art. No.: CD003274. doi:10.1002/14651858.CD003274.
12. Koh M.S., Tee A., Lasserson T.J., Irving L.B. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev 2007, CD002739.
13. Castro-Rodriguez J.A., Rodrigo G.J. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009, 123:e519-e525.
14. Rossi G.A., Cerasoli F., Cazzola M. Safety of inhaled corticosteroids: room for improvement. Pulm Pharmacol Ther 2007, 20:23-35.
15. Paton J., Jardine E., McNeill E., Beaton S., Galloway P., Young D., et al. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child 2006, 91:808-813.
16. Dunlop K.A., Carson D.J., Steen H.J., McGovern V., McNaboe J., Shields M.D. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Arch Dis Child 2004, 89:713-716.
17. Sim D., Griffiths A., Armstrong D., Clarke C., Rodda C., Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Respir J 2003, 21:633-636.
18. Eid N., Morton R., Olds B., Clark P., Sheikh S., Looney S. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 2002, 109:217-221.
19. Todd G.R., Acerini C.L., Ross-Russell R., Zahra S., Warner J.T., McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002, 87:457-461.
20. Pedersen S. Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks?. Arch Dis Child 2008, 93:644-645.
21. Kelly H.W., van Natta M.L., Covar R.A., Tonascia J., Green R.P., Strunk R.C. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008, 122:e53-e61.
22. Masoli M., Weatherall M., Holt S., Beasley R. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 2004, 89:902-907.
23. Leone F.T., Fish J.E., Szefler S.J., West S.L. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003, 124:2329-2340.
24. Brand P.L.P. Inhaled corticosteroids reduce growth. Or do they?. Eur Respir J 2001, 17:287-294.
25. Pedersen S. Do inhaled corticosteroids inhibit growth in children?. Am J Respir Crit Care Med 2001, 164:521-535.
26. Agertoft L., Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with astma. N Engl J Med 2000, 343:1064-1069.
27. Laforest L., El Hasnaoui A., Pribil C., Ritleng C., Osman L.M., Schwalm M.S., et al. Asthma patients' self-reported behaviours toward inhaled corticosteroids. Respir Med 2009, 103:1366-1375.
28. Klok T., Brand P.L., Bomhof-Roordink H., Duiverman E.J., Kaptein A.A. Parental illness perceptions and medication perceptions in childhood asthma, a focus group study. Acta Paediatr 2011, 100:248-252.
29. Bianchi M., Clavenna A., Bonati M. Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period. Eur J Clin Pharmacol 2010, 66:929-936.
30. Kemp J.P., Dockhorn R.J., Shapiro G.G., Nguyen H.H., Reiss T.F., Seidenberg B.C., et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 1998, 133:424-428.
31. Grzelewski T., Stelmach I. Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options. Drugs 2009, 69:1533-1553.
32. Fogel R.B., Rosario N., Aristizabal G., Loeys T., Noonan G., Gaile S., et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 2010, 104:511-517.
33. Stelmach I., Grzelewski T., Majak P., Jerzynska J., Stelmach W., Kuna P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008, 121:383-389.
34. Li A.M., Abdullah V.J., Tsen C.S., Au C.T., Lam H.S., So H.K., et al. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study. Pediatr Pulmonol 2009, 44:1085-1092.
35. de Groot H., Brand P.L., Fokkens W.F., Berger M.Y. Allergic rhinoconjunctivitis in children. BMJ 2007, 335:985-988.
36. Chen S.T., Lu K.H., Sun H.L., Chang W.T., Lue K.H., Chou M.C. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol 2006, 17:49-54.
37. Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005, 171:315-322.
38. Robertson C.F., Price D., Henry R., Mellis C., Glasgow N., Fitzgerald D., et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007, 175:323-329.
39. Weiss K.B., Gern J.E., Johnston N.W., Sears M.R., Jones C.A., Jia G., et al. The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year. Ann Allergy Asthma Immunol 2010, 105:174-181.
40. Todi V.K., Lodha R., Kabra S.K. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial. Arch Dis Child 2010, 95:540-543.
41. Castro-Rodriguez J.A., Rodrigo G.J. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch Dis Child 2010, 95:365-370.
42. Jónasson G., Carlsen K.H., Jonasson C., Mowinckel P. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy 2000, 55:740-748.
43. Rand C., Bilderback A., Schiller K., Edelman J.M., Hustad C.M., Zeiger R.S. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 2007, 119:916-923.
44. Celano M.P., Linzer J.F., Demi A., Bakeman R., Smith C.O., Croft S., et al. Treatment adherence among low-income, African American children with persistent asthma. J Asthma 2010, 47:317-322.
45. McNally K.A., Rohan J., Schluchter M., Riekert K.A., Vavrek P., Schmidt A., et al. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged african american youth with asthma. J Asthma 2009, 46:921-927.
46. Gruchalla R.S., Sampson H.A., Matsui E., David G., Gergen P.J., Calatroni A., et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol 2009, 124:213-221. 221.
47. Stempel D.A., Pinto L., Stanford R.H. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. J Allergy Clin Immunol 2002, 110:39-41.